Suppliers / Padagis Israel

Padagis Israel

Israel 71 employees Updated 9 July 2026

Padagis Israel is a finished-dose manufacturer based in Israel. It appears in 43 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 27 October 2022 as NAI.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
43
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 27 October 2022 NAI US FDA
  • 13 June 2019 NAI US FDA
  • 19 July 2018 NAI US FDA
  • 22 January 2015 VAI US FDA
  • 27 August 2012 VAI US FDA
  • 28 January 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Shoham, Israel Not on file
Israel, Israel 3001904238
Yeruham, Israel Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 43 None
EMA None 12

Questions about Padagis Israel

Does Padagis Israel hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Padagis Israel. It does have 43 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Is Padagis Israel FDA-registered?
One site operated by Padagis Israel carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Padagis Israel's last inspection go?
The most recent inspection on record closed on 27 October 2022 as NAI (No Action Indicated: nothing objectionable was found). 6 inspections are on file.
Where does Padagis Israel manufacture?
3 registered sites are on record, in Israel (Shoham, Israel and Yeruham). Every site is listed on this page with the register it came from.
Which regulators recognise Padagis Israel's GMP?
Current GMP certificates are on record from EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Padagis Israel comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 11 active litigation matters are on record.
  • The most recent inspection outcome was NAI, on 27 October 2022.

Comparable suppliers

Abic also in Israel Dexcel Pharma also in Israel Rafa Laboratories also in Israel Taro Pharmaceuticals also in Israel Finetech Pharmaceutical also in Israel

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates